Publication | Closed Access

Long-term monitoring drug resistance by ultra-deep pyrosequencing in a chronic hepatitis B virus (HBV)-infected patient exposed to several unsuccessful therapy schemes

HepatologyViral HepatitisPharmacologyHepatitis BHepatitisAntiviral TherapyUltra-deep PyrosequencingPharmacotherapyMedicineDrug DiscoveryDrug Resistance